Atherosclerosis and Lipoproteins |
From The Scripps Research Institute, Department of Immunology, La Jolla, Calif.
Reprint requests to Linda K. Curtiss, The Scripps Research Institute, Department of Immunology, IMM17, 10550 N Torrey Pines Rd, La Jolla, CA 92037. E-mail lcurtiss{at}scripps.edu
Objective Natural killer (NK) cells have been identified in human vascular pathologies. In this study, we identified NK cells in aortic root atherosclerotic lesions of low density lipoprotein (LDL) receptordeficient (LDLr-/-) mice. To characterize the role of NK cellmediated cytolysis in atherosclerosis, we generated C57Bl/6 double-mutant mice by crossing LDLr-/- mice with NK celldefective Lystbeige mice (creating beige,LDLr-/- mice) and with perforin-deficient mice (creating Pfp-/-,LDLr-/- mice).
Methods and Results Male mice (8 to 10 weeks old) were fed a high-fat diet to induce atherosclerosis. Compared with LDLr-/- mice, beige,LDLr-/- mice had impaired NK cell cytolytic activity and significantly increased atherosclerosis (P<0.05). Pfp-/-,LDLr-/- mice had impaired NK cell cytolytic activity, yet they had lesions that were similar to those of control mice. This suggested that NK cell cytolysis did not play a significant role in atherosclerosis and that the exacerbated atherosclerosis of the beige,LDLr-/- mouse was independent of impaired NK cell cytolytic activity. Therefore, we investigated the role of T and B lymphocytes in atherosclerosis of beige mice by crossing them with recombinase activator gene 1deficient LDLr-/- mice (Rag1-/-,LDLr-/- mice), thus creating beige,Rag1-/-, LDLr-/- mice. As in the double-mutant study, beige,Rag1-/-,LDLr-/- mice had significantly increased lesions compared with Rag1-/-,LDLr-/- control mice.
Conclusions Therefore, the Lystbeige mutation in LDLr-/- mice has proatherogenic properties that are independent of NK cellmediated cytolysis and lymphocyte-mediated acquired immunity.
Key Words: atherosclerosis perforin Chédiak-Higashi syndrome lysosome natural immunity
This article has been cited by other articles:
![]() |
R. J. Petrovan, Y. Yuan, and L. K. Curtiss Expression of the Lystbeige mutation is atheroprotective in chow-fed apolipoprotein E-deficient mice J. Lipid Res., February 1, 2008; 49(2): 429 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. VanderLaan and C. A. Reardon Thematic review series: The Immune System and Atherogenesis. The unusual suspects:an overview of the minor leukocyte populations in atherosclerosis J. Lipid Res., May 1, 2005; 46(5): 829 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Getz Bridging the innate and adaptive immune systems J. Lipid Res., April 1, 2005; 46(4): 619 - 622. [Full Text] [PDF] |
||||
![]() |
N. K. Schiller, A. S. Black, G. P. Bradshaw, D. J. Bonnet, and L. K. Curtiss Participation of macrophages in atherosclerotic lesion morphology in LDLr-/- mice J. Lipid Res., August 1, 2004; 45(8): 1398 - 1409. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Linton, A. S. Major, and S. Fazio Proatherogenic Role for NK Cells Revealed Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 992 - 994. [Full Text] [PDF] |
||||
![]() |
S. C. Whitman, D. L. Rateri, S. J. Szilvassy, W. Yokoyama, and A. Daugherty Depletion of Natural Killer Cell Function Decreases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 1049 - 1054. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Getz Do Natural Killer Cells Participate in a Killer Vascular Disease? Arterioscler Thromb Vasc Biol, August 1, 2002; 22(8): 1251 - 1253. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |